Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from GSK

FDA approves United States' first-ever RSV vaccine

GSK's RSV vaccine is approved for people aged 60 and older.

Axios

GSK Stock Jumps After Beating Pfizer, Moderna To The RSV Vaccine Finish Line

GSK stock jumped Wednesday after the drugmaker won the first-ever approval for an RSV vaccine, leading rivals Pfizer and Moderna.

Investors Business Daily

US approves first vaccine for RSV after decades of attempts

The US has approved the first vaccine for RSV, shots to protect older adults

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Drug Heavyweights GSK, Roche Topple As Covid Weighs On Sales Growth

GSK leaned on vaccines while Roche relied on pharmaceutical sales to outplay Covid declines. But shares of both fell Tuesday.

Investors Business Daily

New CBI boss says she is ‘profoundly sorry’ to women let down by group

Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry

The Guardian - UK

End of the road for Covid turnover, GSK says

GSK has signalled the end of the road for its Covid drug sales boom as the pharma giant eyes fresh sources of revenue to plug the hole left by the subsidence of the pandemic.

Evening Standard

FTSE 100 Live: ‘A radical decline in UK investment’ — London Stock Exchange boss grilled on US listings

GSK, housebuilder Persimmon and the consumer products group Reckitt Benckiser are among the blue-chips updating investors today.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

The Guardian - UK

GSK workers to strike after rejecting pay offer

Workers at sites in Irvine and Montrose are set to walk out next month

Insider UK

Stocks Close Slightly Higher Despite Bank Stock Weakness and Hawkish Fed Comments

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.03%. The S&P 500 and Nasdaq 100 indexes Tuesday settled...

Barchart

Stocks Fall Back on Bank Stocks and Hawkish Bullard

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.42%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.08%. U.S. stock indexes gave up early gains and are...

Barchart

Bellus Health Soars 99% As GSK Joins Buyout Bonanza With $2 Billion Deal

GSK added to a series of recent takeovers Tuesday with the $2 billion acquisition of Bellus Health. But BLU stock and GSK stock diverged.

Investors Business Daily

GSK unveils £1.6 billion deal to buy Canadian medicine maker Bellus Health and its blockbuster cough drug

The deal is the biggest since the old GlaxoSmithKline split in two by separating its consumer products arm

Evening Standard

Dianne Feinstein is still out with shingles. Did she get GSK’s vaccine?

Dianne Feinstein’s return to the U.S. Senate has been delayed by complications from shingles. The risk of contracting that debilitating disease can be sharply reduced with the Shingrix vaccine, made by GSK, which has its U.S. headquarters in Philadelphia.

The Philadelphia Inquirer

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Oxford malaria vaccine wins first approval from Ghana in ‘significant milestone’

600,000 die every year from the disease, mostly children in Africa

The Conversation

New asthma medicine restrictions will hurt the poorest children the most

Last week, without warning, the federal government significantly restricted the subsidy for an important and safe asthma medicine for children. A short document explained to prescribers what had changed, but gave no reasons.

StockNews.com

3 Top-Rated Companies to Buy Today

Amid the Fed’s monetary policy tightening and the recent financial sector turmoil, fears of an economic slowdown have soared, which in turn induced market volatility. Given this backdrop, quality stocks Comcast Corp. (CMCSA), Medtronic (MDT), and GSK plc (GSK) might be solid buys today. Read on….

AAP

New study recommends better vaccine deal for adults

Older Australians are being left behind by Australia's national immunisation program, with health advocates calling on the government to reform the system.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

Investors Business Daily

GSK Stock Skids On Judge's New Ruling As Zantac Trial Looms

A California judge will allow expert testimony linking GSK's heartburn drug Zantac to cancer. The decision took a bite out of GSK stock Friday.

Asharq Al-Awsat

Burberry Appoints McLaren's Kate Ferry as CFO

British luxury brand Burberry said on Wednesday it had appointed Kate Ferry as its next chief financial officer, succeeding Julie Brown, who is joining GSK. Ferry, who is currently chief financial officer at Formula One and luxury car firm McLaren Group, will join Burberry by early September at the latest,…

Daily Mirror

Joe Lycett and Sam Smith lead Rainbow Honours nominees as iconic venue for awards revealed

Joe Lycett's protest against David Beckham's controversial deal with Qatar has been nominated for yet another prestigious award, with Sam Smith, Graham Norton, Andrew Garfield, Dame Kelly Holmes and more also recognised in the Rainbow Honours shortlist

Fortune

Pfizer’s RSV vaccine just won an FDA panel’s backing for safety in older people. It's a market that will be worth up to $10 billion in a decade

Pfizer is also facing off with collaborators Sanofi and AstraZeneca Plc to develop prevention for dangerous RSV infections in newborns, a market that could reach $1.5 billion.

Tribune News Service

Pfizer’s RSV vaccine wins US panel’s backing for safety in older people

WASHINGTON — Pfizer Inc.’s vaccine for respiratory syncytial virus received endorsement from a key panel of U.S. advisers for its safety in people 60 and older, a key endorsement for the drugmaker’s potential product.

Wales Online

Eamonn Holmes talks putting personal and work life on hold as thanks to shingles

"I wasn’t aware of what I had; I looked in the mirror, I had no idea what I was looking at except this hideously blistered face"

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.